These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9777977

  • 1. The future of recombinant growth factors in wound healing.
    Robson MC, Mustoe TA, Hunt TK.
    Am J Surg; 1998 Aug; 176(2A Suppl):80S-82S. PubMed ID: 9777977
    [Abstract] [Full Text] [Related]

  • 2. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.
    Nagai MK, Embil JM.
    Expert Opin Biol Ther; 2002 Feb; 2(2):211-8. PubMed ID: 11849120
    [Abstract] [Full Text] [Related]

  • 3. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
    LeGrand EK.
    Am J Surg; 1998 Aug; 176(2A Suppl):48S-54S. PubMed ID: 9777972
    [Abstract] [Full Text] [Related]

  • 4. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers.
    Miller MS.
    J Foot Ankle Surg; 1999 Aug; 38(3):227-31. PubMed ID: 10384364
    [Abstract] [Full Text] [Related]

  • 5. Growth factors in clinical practice.
    Köveker GB.
    Int J Clin Pract; 2000 Nov; 54(9):590-3. PubMed ID: 11220987
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ, Smiell JM, Su Y.
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [Abstract] [Full Text] [Related]

  • 7. Growth factors and chronic wound healing: past, present, and future.
    Goldman R.
    Adv Skin Wound Care; 2004 May; 17(1):24-35. PubMed ID: 14752324
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.
    Embil JM, Papp K, Sibbald G, Tousignant J, Smiell JM, Wong B, Lau CY.
    Wound Repair Regen; 2000 May; 8(3):162-8. PubMed ID: 10886806
    [Abstract] [Full Text] [Related]

  • 9. How growth factors help chronic wounds heal.
    Barry M.
    Nursing; 2000 May; 30(5):52-3. PubMed ID: 10855193
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
    Wu L, Brucker M, Gruskin E, Roth SI, Mustoe TA.
    Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group.
    Wieman TJ.
    Am J Surg; 1998 Aug; 176(2A Suppl):74S-79S. PubMed ID: 9777976
    [Abstract] [Full Text] [Related]

  • 13. Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee.
    Ladin D.
    Plast Reconstr Surg; 2000 Mar; 105(3):1230-1. PubMed ID: 10724287
    [Abstract] [Full Text] [Related]

  • 14. Platelet-rich plasma: support for its use in wound healing.
    Lacci KM, Dardik A.
    Yale J Biol Med; 2010 Mar; 83(1):1-9. PubMed ID: 20351977
    [Abstract] [Full Text] [Related]

  • 15. [New developments in the treatment of diabetic foot ulcers].
    Bakker K, Schaper NC.
    Ned Tijdschr Geneeskd; 2000 Feb 26; 144(9):409-12. PubMed ID: 10719543
    [Abstract] [Full Text] [Related]

  • 16. Use of Regranex gel for diabetic foot ulcers.
    Piascik P.
    J Am Pharm Assoc (Wash); 1998 Feb 26; 38(5):628-30. PubMed ID: 9782698
    [No Abstract] [Full Text] [Related]

  • 17. Effects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGF-BB) and becaplermin gel.
    Castronuovo JJ, Ghobrial I, Giusti AM, Rudolph S, Smiell JM.
    Am J Surg; 1998 Aug 26; 176(2A Suppl):61S-67S. PubMed ID: 9777974
    [Abstract] [Full Text] [Related]

  • 18. Healing and preventing the diabetic foot wound: where technology, economics and common sense converge.
    Armstrong DG.
    Indian J Med Sci; 2007 Jun 26; 61(6):324-5. PubMed ID: 17558094
    [No Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
    Sibbald RG, Torrance G, Hux M, Attard C, Milkovich N.
    Ostomy Wound Manage; 2003 Nov 26; 49(11):76-84. PubMed ID: 14652415
    [Abstract] [Full Text] [Related]

  • 20. Effect of platelet-derived growth factor-BB on bone formation in calvarial defects: an experimental study in rabbits.
    Vikjaer D, Blom S, Hjørting-Hansen E, Pinholt EM.
    Eur J Oral Sci; 1997 Feb 26; 105(1):59-66. PubMed ID: 9085030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.